DK1355650T3 - Kombination af aktive bestanddele, som indeholder alfuzosin og apomorphin - Google Patents

Kombination af aktive bestanddele, som indeholder alfuzosin og apomorphin

Info

Publication number
DK1355650T3
DK1355650T3 DK02711823T DK02711823T DK1355650T3 DK 1355650 T3 DK1355650 T3 DK 1355650T3 DK 02711823 T DK02711823 T DK 02711823T DK 02711823 T DK02711823 T DK 02711823T DK 1355650 T3 DK1355650 T3 DK 1355650T3
Authority
DK
Denmark
Prior art keywords
apomorphine
active ingredients
combination
ingredients containing
containing alfuzosin
Prior art date
Application number
DK02711823T
Other languages
Danish (da)
English (en)
Inventor
Sonia Arbilla
Juan Fernando Ramirez
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1355650T3 publication Critical patent/DK1355650T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK02711823T 2001-01-19 2002-01-18 Kombination af aktive bestanddele, som indeholder alfuzosin og apomorphin DK1355650T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01400166A EP1224933A1 (de) 2001-01-19 2001-01-19 Neue Kombination mit Alfuzosin und Apomorphin als Aktiva

Publications (1)

Publication Number Publication Date
DK1355650T3 true DK1355650T3 (da) 2006-05-15

Family

ID=8182601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02711823T DK1355650T3 (da) 2001-01-19 2002-01-18 Kombination af aktive bestanddele, som indeholder alfuzosin og apomorphin

Country Status (10)

Country Link
US (1) US20040063736A1 (de)
EP (2) EP1224933A1 (de)
JP (1) JP2004517141A (de)
AT (1) ATE314073T1 (de)
DE (1) DE60208336T2 (de)
DK (1) DK1355650T3 (de)
ES (1) ES2254657T3 (de)
PT (1) PT1355650E (de)
SI (1) SI1355650T1 (de)
WO (1) WO2002056887A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
JP3310982B2 (ja) * 1994-04-22 2002-08-05 ペンテツク・フアーマシユーテイカルズ・インコーポレイテツド 男性の勃起機能不全を改善するための剤形及び方法
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
EP1027054A4 (de) * 1997-10-28 2002-11-04 Vivus Inc Lokale anwendung von phosphodiesterase inhibitoren zur behandlung der erektilen dysfunktion

Also Published As

Publication number Publication date
DE60208336D1 (de) 2006-02-02
EP1355650A1 (de) 2003-10-29
ATE314073T1 (de) 2006-01-15
EP1355650B1 (de) 2005-12-28
DE60208336T2 (de) 2006-09-07
WO2002056887A1 (en) 2002-07-25
EP1224933A1 (de) 2002-07-24
PT1355650E (pt) 2006-05-31
ES2254657T3 (es) 2006-06-16
JP2004517141A (ja) 2004-06-10
US20040063736A1 (en) 2004-04-01
SI1355650T1 (sl) 2006-06-30

Similar Documents

Publication Publication Date Title
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
HRP20040059B1 (hr) Tretman infekcije nokta s no
MXPA03007140A (es) Derivados de carbolina.
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
SE0100901D0 (sv) New composition
PL358004A1 (en) Pteridine compounds for the treatment of psoriasis
DK1363608T3 (da) Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
YU60903A (sh) Kompozicija i antivirusna aktivnost derivata supstituisanog azaindoloksoacetat piperazina
EA200501690A1 (ru) Композиция, включающая ингибитор pde4 и ингибитор pde5
AP2003002929A0 (en) Pyrrolopyrimidines as protein kinase inhibitors
TR200502508T2 (tr) IL-18 İnhibitörlerinin kullanımı.
AR034231A1 (es) Composicion farmaceutica que contiene mosaprida y pancreatina
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
SE0101932D0 (sv) Pharmaceutical combinations
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
DK1694660T3 (da) Fremgangsmåde til fremstilling af vandfri og hydrerede aktive farmaceutiske bestanddele (API's); stabile farmaceutiske sammensætninger fremstillet af disse og anvendelser af disse sammensætninger
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
DK1355650T3 (da) Kombination af aktive bestanddele, som indeholder alfuzosin og apomorphin
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
HUP0402654A2 (hu) 2-[(2'-Halogén-3',5'-dialkoxi-fenil)-imino]-imidazolidin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
DK1523985T3 (da) Ikke-radioaktivt strontiumholdigt middel til behandling af kræft